DM Capital logo

DM Capital

Asia, Guangdong, China, Shenzhen

Description

DM Capital is the holding company of DM Fund Management Limited (Cayman), which solely manages DM Harmony Fund

Investor Profile

DM Capital has made 5 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (60%)
  • Series A (40%)

Country Focus

  • United States (60%)
  • Japan (20%)
  • Switzerland (20%)

Industry Focus

  • Biotechnology
  • Manufacturing
  • Health Care
  • Medical
  • Rental
  • Construction
  • Wellness
  • Health Diagnostics
  • Precision Medicine
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does DM Capital frequently co-invest with?

Kyogin Lease & Capital
Asia, Kyoto, Japan, Kyoto
Co-Investments: 1
SMBC Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Asahi Kasei Corporate Venture Capital
North America, California, United States, Menlo Park
Co-Investments: 1
CV
Asia, Kyoto, Japan, Kyoto
Co-Investments: 1
Kyoto University Innovation Capital
Asia, Kyoto, Japan, Kyoto
Co-Investments: 1
Shimadzu
Asia, Kyoto, Japan, Kyoto
Co-Investments: 1
Bold Capital Partners
North America, California, United States, Santa Monica
Co-Investments: 1
Healthcare Innovation
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Mitsubishi UFJ Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
M3
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1

What are some of recent deals done by DM Capital?

MimiX Biotherapeutics

Neuchâtel, Neuchatel, Switzerland

mimiX Biotherapeutics provides a point-of-care tissue engineering approach to regenerative, patient-tailored precision medicine.

BiotechnologyHealth DiagnosticsManufacturingPrecision MedicineTherapeutics
SeedDec 21, 2022
Rege Nephro

Kyoto, Kyoto, Japan

Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.

BiotechnologyManufacturingMedicalRental
Series AJan 31, 2022
Sigilon Therapeutics

Cambridge, Massachusetts, United States

Sigilon Therapeutics is a biotech company that specializes in creating immune-privileged products for treating acute and chronic diseases.

BiotechnologyHealth CareWellness
Series AApr 1, 2018
Amount Raised: $13,100,000
iviva medical

Beverly, Massachusetts, United States

IVIVA Medical was founded with the goal of developing autologous tissue constructs as a solution to end-state kidney disease (ESKD).

Construction
SeedMar 1, 2018
Ulab Systems

Memphis, Tennessee, United States

Ulab Systems develops a breakthrough software technology for digital dental treatment planning.

Consumer SoftwareHealth CareSoftware
SeedSep 1, 2017
Amount Raised: $4,920,000